This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bucki, R. Articles by Janmey, P. A. Search for Related Content PubMed PubMed Citation Articles by Bucki, R. Articles by Janmey, P. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2006, p. 2932-2940, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00134-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Interaction of the Gelsolin-Derived Antibacterial PBP 10 Peptide with Lipid Bilayers and Cell Membranes

Department of Physiology and Institute for Medicine and Engineering, University of Pennsylvania, 1080 Vagelos Research Laboratories, 3340 Smith Walk, Philadelphia, Pennsylvania 19104

Received 1 February 2006/ Returned for modification 29 March 2006/ Accepted 9 June 2006

PBP 10, an antibacterial, cell membrane-permeant rhodamine B-conjugated peptide derived from the polyphosphoinositide binding site of gelsolin, interacts selectively with both lipopolysaccharides (LPS) and lipoteichoic acid (LTA), the distinct components of gram-negative and gram-positive bacteria, respectively. Isolated LPS and LTA decrease the antimicrobial activities of PBP 10, as well as other antimicrobial peptides, such as cathelicidin-LL37 (LL37) and mellitin. In an effort to elucidate the mechanism of bacterial killing by PBP 10, we compared its effects on artificial lipid bilayers and eukaryotic cell membranes with the actions of the mellitin, magainin II, and LL37 peptides. This study reveals that pore formation is unlikely to be involved in PBP 10-mediated membrane destabilization. We also investigated the effects of these peptides on platelets and red blood cells (RBCs). Comparison of these antimicrobial peptides shows that only mellitin has a toxic effect on platelets and RBCs in a concentration range concomitant with its bactericidal activity. The hemolytic activities of the PBP 10 and LL37 peptides significantly increase when RBCs are osmotically swollen in hypotonic solution, indicating that these antibacterial peptides may take advantage of the more extended form of bacterial membranes in exerting their killing activities. Additionally, we found that LL37 hemolytic activity was much higher when RBCs were induced to expose phosphatidylserine to the external leaflet of their plasma membranes. This finding suggests that asymmetrical distribution of phospholipids in the external membranes of eukaryotic cells may represent an important factor in determining the specificity of antibacterial peptides for targeting bacteria rather than eukaryotic cells.

This article has been cited by other articles:

• Bucki, R., Byfield, F. J., Kulakowska, A., McCormick, M. E., Drozdowski, W., Namiot, Z., Hartung, T., Janmey, P. A. (2008). Extracellular Gelsolin Binds Lipoteichoic Acid and Modulates Cellular Response to Proinflammatory Bacterial Wall Components. J. Immunol. 181: 4936-4944 [Abstract] [Full Text]  
• Hermelink, A., Brezesinski, G. (2008). Do unsaturated phosphoinositides mix with ordered phosphadidylcholine model membranes?. J. Lipid Res. 49: 1918-1925 [Abstract] [Full Text]  
• Bucki, R., Sostarecz, A. G., Byfield, F. J., Savage, P. B., Janmey, P. A. (2007). Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother 60: 535-545 [Abstract] [Full Text]  
• Bucki, R., Byfield, F. J., Janmey, P. A. (2007). Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur Respir J 29: 624-632 [Abstract] [Full Text]